Colinz Labs Reports Strong Financial Performance in Q2 of FY 2024-2025

Nov 05 2024 04:39 PM IST
share
Share Via
Colinz Laboratories, a microcap pharmaceutical company, has announced its financial results for the quarter ending September 2024. Despite being given a 'Sell' call by MarketsMojo, the company has shown positive performance with the highest annual operating cash flow and quarterly profits in the last five quarters. The company's EPS and liquidity have also improved.
Colinz Laboratories, a microcap pharmaceutical company, has recently announced its financial results for the quarter ending September 2024. The company's stock has been given a 'Sell' call by MarketsMOJO.

Despite this, Colinz Labs has shown positive financial performance in the second quarter of the fiscal year 2024-2025. In the last three months, the company's score has improved from 7 to 9.

According to the September 2024 financials, Colinz Labs has several factors working in its favor. The company has generated the highest annual operating cash flow of Rs 1.03 crore in the last three years, indicating strong cash revenues from business operations. Additionally, the company's quarterly operating profit (PBDIT) has been the highest at Rs 0.17 crore in the last five quarters, showing a positive trend in the near term. The same can be said for the company's quarterly profit before tax less other income (PBT) and profit after tax (PAT), which have both been the highest in the last five quarters.

Furthermore, Colinz Labs has also shown an increase in earnings per share (EPS) in the last five quarters, with the highest being Rs 0.63. This indicates that the company has been able to create higher earnings for its shareholders. In terms of liquidity, the company's cash and cash equivalents have been the highest at Rs 8.04 crore in the last six half-yearly periods, showing an improvement in short-term liquidity. Additionally, the company has been able to settle its debtors faster, with the debtors turnover ratio being the highest at 8.48 times in the last five half-yearly periods.

Overall, Colinz Laboratories has shown positive financial performance in the recent quarter, with several factors working in its favor. Investors should keep an eye on the company's future performance to make informed decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Colinz Labs falling/rising?
Dec 11 2025 12:32 AM IST
share
Share Via
Why is Colinz Labs falling/rising?
Nov 14 2025 09:44 PM IST
share
Share Via
Colinz Laboratories Hits New 52-Week Low at Rs. 36.11
Nov 13 2025 09:58 AM IST
share
Share Via
Colinz Laboratories Hits New 52-Week Low at Rs. 37.4
Nov 11 2025 02:13 PM IST
share
Share Via
Why is Colinz Labs falling/rising?
Nov 06 2025 09:25 PM IST
share
Share Via